# To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea

> **NCT01259778** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 224 (actual)

## Conditions studied

- Growth Disorders

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01259778
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02-28
- **Primary completion:** 2015-12-31
- **Final completion:** 2015-12-31
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2017-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01259778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01259778, "To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in South Korea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01259778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*